Cerevel Therapeutics Hldg Inc (CERE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CERE | CRNX | STVN | ||
| Company | Cerevel Therapeutics Hldg Inc | Crinetics Pharmaceuticals Inc | Stevanato Group S.P.A. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 44.99 | 84.96 | 20.64 | ||
| High | 44.99 | 85.01 | 21.23 | ||
| Low | 44.96 | 84.92 | 20.47 | ||
| Last | 44.96 | 84.95 | 20.53 | ||
| Change | +0.33 | +0.11 | -0.18 | ||
| Percent Change | +0.74% | +0.13% | -0.87% | ||
| Volume | 15,096,300 | 8,208,400 | 111,610 | ||
| 20-Day Average Volume | 2,839,210 | 2,566,585 | 440,157 | ||
| Previous | 44.63 | 84.84 | 20.71 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 42.53 | 84.53 | 21.43 | ||
| 20-Day Raw Stochastic | 99.49% | 95.24% | 24.13% | ||
| 20-Day Relative Strength | 68.05 | 87.56 | 49.91 | ||
| Weighted Alpha | +49.03 | +35.05 | -5.08 | ||
| Today's Opinion | 72% Buy | 100% Buy | 80% Buy | ||
| Yesterday's Opinion | 72% Buy | 100% Buy | 80% Buy | ||
| Last Month's Opinion | 8% Buy | 88% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.67% since 07/24/24 | +0.20% since 08/24/26 | -7.89% since 08/26/26 | ||
| Low | 43.75 on 07/25/24 | 84.78 on 08/25/26 | 20.61 on 09/02/26 | ||
| High | 44.99 on 07/31/24 | 85.01 on 08/31/26 | 22.64 on 08/27/26 | ||
| 1-Month | |||||
| %Chg | +9.95% since 06/28/24 | +1.71% since 07/31/26 | +3.85% since 07/31/26 | ||
| Low | 39.16 on 07/03/24 | 83.62 on 08/03/26 | 19.00 on 08/04/26 | ||
| High | 44.99 on 07/31/24 | 85.01 on 08/31/26 | 23.18 on 08/24/26 | ||
| 3-Month | |||||
| %Chg | +5.27% since 04/30/24 | +138.96% since 05/29/26 | +9.71% since 06/02/26 | ||
| Low | 38.50 on 06/25/24 | 32.30 on 06/02/26 | 16.27 on 06/16/26 | ||
| High | 44.99 on 07/31/24 | 85.01 on 08/31/26 | 23.18 on 08/24/26 | ||
| 6-Month | |||||
| %Chg | +6.82% since 01/30/24 | +106.69% since 02/27/26 | +36.61% since 03/02/26 | ||
| Low | 38.50 on 06/25/24 | 32.30 on 06/02/26 | 12.89 on 03/27/26 | ||
| High | 44.99 on 07/31/24 | 85.01 on 08/31/26 | 23.18 on 08/24/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,191,488 | 9,010,222 | 6,271,878 | ||
| Shares Outstanding, K | 182,195 | 106,065 | 302,843 | ||
| Annual Sales, $M | 0 | 7,700,000 | 1,342,160,000 | ||
| Annual Net Income, $M | -432,840,000 | -465,320,000 | 158,210,000 | ||
| Last Qtr Sales, $M | 0 | 25,120,000 | 351,140,000 | ||
| Last Qtr Income, $M | -131,910,000 | -120,860,000 | 26,690,000 | ||
| 60-Month Beta | 1.40 | 0.12 | 0.74 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.73 on 05/08/24 | -1.14 on 08/03/26 | 0.16 on 08/04/26 | ||
| Latest Earnings Date | 08/07/24 | 11/05/26 | 11/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 32.47 | ||